SQM Rating

SQM Rating

HMC Capital High Conviction Alternatives Fund has been rated by SQM Research in March 2023. The rating of 3.75 stars was awarded to the fund.

For further details on the rating, please refer to SQM research or contact invest@hmccapital.com.au for a copy of the report if you are a licenced financial adviser.

 


Disclaimer

The rating contained on this website is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Related

HMC Capital Full Year FY24 Results
ASX Announcement HMC Capital Partners Fund

HMC Capital Full Year FY24 Results

HomeCo Daily Needs REIT (ASX: HDN) today released its full year FY24 results
ASX Announcement HMC Capital Partners Fund HomeCo Daily Needs REIT Real Estate

HomeCo Daily Needs REIT (ASX: HDN) today released its full year FY24 results

HealthCo Healthcare & Wellness REIT (ASX: HCW) today released its full year FY24 results
ASX Announcement HealthCo Healthcare & Wellness REIT HMC Capital Partners Fund Real Estate

HealthCo Healthcare & Wellness REIT (ASX: HCW) today released its full year FY24 results